12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Elafin: Phase II started

Proteo began the double-blind, placebo-controlled, U.K. Phase II EMPIRE trial to evaluate intraoperative Elafin in 80 patients undergoing coronary bypass surgery. Medical Research Council (MRC) and Chest Heart & Stroke Scotland (CHSS) will provide...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >